University of Bonn

Bonn D-53105

2 studies enrolling now · 15 studies all time

What they study most

AMD, Acquired Immunodeficiency Syndrome, Age-Related Macular Degeneration, General Anesthesia, Geographic Atrophy, HIV, HIV Infections, HIV-1 Infection, Heart Block Complete, Heart Block Second Degree, Hepatocellular Carcinoma, Intracerebral Hemorrhage

Studies at this site

• Slow Heart Registry of Fetal Immune-mediated High Degree Heart Block — Recruiting now
• Zimura Compared to Sham in Patients With Autosomal Recessive Stargardt Disease (STGD1) — Completed
• Study of Serine Supplementation to Protect Vision in MacTel — Starting soon
• A Phase 3 Safety and Efficacy Study of Intravitreal Administration of Zimura (Complement C5 Inhibitor) — Completed
• Study to Evaluate Switching From a TDF-Containing Combination Regimen to a TAF-Containing Fixed Dose Combination (FDC) in Virologically-Suppressed, HIV-1 Positive Participants — Completed
• The REFLECT Trial: Cerebral Protection to Reduce Cerebral Embolic Lesions After Transcatheter Aortic Valve Implantation — Completed
• Switch Study to Evaluate the Safety and Efficacy of Emtricitabine/Rilpivirine/Tenofovir Alafenamide (FTC/RPV/TAF) Fixed Dose Combination (FDC) in HIV-1 Positive Adults Who Are Virologically Suppressed on Emtricitabine/Rilpivirine/Tenofovir Disoproxil Fumarate (FTC/RPV/TDF) — Completed
• Study to Evaluate Switching From a Regimen Consisting of Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate (EFV/FTC/TDF) Fixed Dose Combination (FDC) to Emtricitabine/Rilpivirine/Tenofovir Alafenamide (FTC/RPV/TAF) FDC in Virologically-Suppressed, HIV-1 Infected Adults — Completed
• The Second Multicenter Hemophilia Cohort Study — Completed
• Minimally Invasive Surgery Plus Rt-PA for ICH Evacuation Phase III — Completed
• Protective Ventilation With Higher Versus Lower PEEP During General Anesthesia for Surgery in Obese Patients — Completed
• AMD Phenotype and Genotype Study — Completed
• Antihypertensive Treatment of Acute Cerebral Hemorrhage-II — Stopped early
• Study to Evaluate Switching From Regimens Consisting of a Ritonavir-boosted Protease Inhibitor Plus Emtricitabine/Tenofovir Fixed-Dose Combination to the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Single-Tablet Regimen in Virologically Suppressed, HIV-1 Infected Patients — Completed
• Prospective Study to Identify Patients at Risk of Dangerous Ventricular Arrhythmias — Status unconfirmed